Project Title: “Leveraging Epigenetic Changes in Ovarian Cancer Precursors for Early Detection and Interception”
Kathleen H. Burns, M.D., Ph.D. is the Chair of the Department of Pathology at Dana-Farber Cancer Institute and a Professor of Pathology at Harvard Medical School. Dr. Tom Pisanic is a Senior Research Scientist at The Johns Hopkins Institute for NanoBioTechnology.
Project Title: “Early Detection of Ovarian Cancer with Cell-Free DNA Methylome and Protein Blood Biomarkers”
Robert C. Bast, M.D. (PI) is a Professor of Experimental Therapeutics and Harry Carruthers Wiess Distinguished University Chair at the University of Texas M.D. Anderson Cancer Center. Wenyuan Li, PhD (Co-PI) is an adjunct Professor at the Department of Pathology and Lab Medicine at the University of California Los Angeles.
Project Title: “Engineering theranostic T cells for life-long detection and interception of ovarian cancer”
Leyuan Ma, PhD, is an Assistant Professor of the Department of Pathology and Laboratory Medicine at the Perelman School of Medicine at the University of Pennsylvania. Ronny Drapkin, MD, PhD (Co-PI) is a Franklin Payne Endowed Professor, and the Director of Penn Ovarian Cancer Research Center at the University of Pennsylvania Perelman School of Medicine.
Project Title: “Leveraging Insights from Fallopian Tube Pre-Cancers to Develop Ultrasensitive Biomarkers for Detection of Ovarian Cancer”
David R. Walt, Ph.D. (PI) is a Professor of Pathology at the Department of Pathology at Brigham and Women’s Hospital. Ronny Drapkin, MD, PhD (Co-PI) is a Franklin Payne Endowed Professor, and the Director of Penn Ovarian Cancer Research Center at the University of Pennsylvania Perelman School of Medicine.
Project Title: “Innovative liquid biopsy solutions for ovarian cancer early detection”
Dan A. Landau, MD, PhD (PI) is a Bibliowicz Family Professor of Medicine at Weill Cornell Medicine and Core Member, of the New York Genome Center. Paul Mischel, MD (Co-PI) is a Fortinet Founders Professor; Professor, By Courtesy, at the Department of Neurosurgery and Vice Chair for Research at the Department of Pathology at Stanford University. Adam Widman, MD (Co-PI) is an assistant Member of the Department of Medicine; PI of Widman Lab, Digital Oncology Program at Memorial Sloan Kettering Cancer Center. Ronny Drapkin, MD, PhD (Collaborator) is a Franklin Payne Endowed Professor, and the Director of Penn Ovarian Cancer Research Center at the University of Pennsylvania Perelman School of Medicine.
Project Title: “Integrated MicroRNA-Based Early Detection and Risk Stratification for Ovarian Cancer”
Dr. Chowdhury is a Professor of Medicine at Dana-Farber Cancer Institute/ Harvard Medical School and the Chief of the Division Of Radiation and Genomic Stability and Co-Director of the Center for BRCA and Related Genes. Dr. Kevin Elias is the Lilli and Seth Harris Endowed Chair for Ovarian Cancer Research at Cleveland Clinic, based in Cleveland, OH, with subspecialties in Critical Care Medicine and Gynecologic Oncology.
